[1]陈俊,郑若曦,叶锦霞,等.独活寄生汤治疗大鼠膝骨关节炎的作用机制研究[J].中医正骨,2021,33(11):6-12.
 CHEN Jun,ZHENG Ruoxi,YE Jinxia,et al.Study on mechanism of action of Duhuo Jisheng Tang(独活寄生汤)in treatment of knee osteoarthritis in rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2021,33(11):6-12.
点击复制

独活寄生汤治疗大鼠膝骨关节炎的作用机制研究()
分享到:

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第33卷
期数:
2021年11期
页码:
6-12
栏目:
基础研究
出版日期:
2021-11-20

文章信息/Info

Title:
Study on mechanism of action of Duhuo Jisheng Tang(独活寄生汤)in treatment of knee osteoarthritis in rats
作者:
陈俊1郑若曦2叶锦霞3郑春松2张婷2戴雨婷2洪江从4李民4吴广文2
(1.福建中医药大学中西医结合学院,福建 福州 350122; 2.福建中医药大学中西医结合研究院,福建 福州 350122; 3.福建省中西医结合老年性疾病重点实验室,福建 福州 350122; 4.福建中医药大学附属康复医院,福建 福州 350003)
Author(s):
CHEN Jun1ZHENG Ruoxi2YE Jinxia3ZHENG Chunsong2ZHANG Ting2DAI Yuting2HONG Jiangcong4LI Min4WU Guangwen2
1.College of Integrative Medicine,Fujian University of Traditional Chinese Medicine,Fuzhou 350122,Fujian,China2.Academy of Integrative Medicine,Fujian University of Traditional Chinese Medicine,Fuzhou 350122,Fujian,China3.Fujian Key Laboratory of Integrative Medicine on Geriatrics,Fuzhou 350122,Fujian,China4.Rehabilitation Hospital affiliated to Fujian University of Traditional Chinese Medicine,Fuzhou 350003,Fujian,China
关键词:
骨关节炎 软骨组织 独活寄生汤 大鼠Sprague-Dawley RNA RNA长链非编码 聚集蛋白聚糖 胶原Ⅱ型 动物实验
Keywords:
osteoarthritisknee cartilaginous tissue Duhuo Jisheng Tang ratsSprague-Dawley RNA RNAlong noncoding aggrecans collagen typeⅡ animal experimentation
摘要:
目的:探讨独活寄生汤治疗大鼠膝骨关节炎(knee osteoarthritis,KOA)的作用机制。方法:从66只大鼠中随机选取48只,采用改良Hulth法建立大鼠KOA模型,随机选择3只正常大鼠和3只建模大鼠进行鉴定。证实建模成功后,将剩余的15只正常大鼠纳入正常对照组,采用随机数字表将剩余的45只KOA模型大鼠分为KOA模型组、独活寄生汤治疗组、盐酸氨基葡萄糖治疗组,每组15只。正常对照组、KOA模型组、独活寄生汤治疗组、盐酸氨基葡萄糖治疗组大鼠均按每天10 mL·kg-1分别以0.9%生理盐水、0.9%生理盐水、独活寄生汤(浓度为0.93 g·mL-1)、盐酸氨基葡萄糖溶液(浓度为0.015 g·mL-1)灌胃,连续干预12周。12周后,切取大鼠双侧胫骨近端和股骨下端的软骨组织。采用实时定量PCR检测大鼠胫骨近端软骨组织中miR-675-3p、长链非编码RNA(long non-coding RNA,lncRNA)H19及聚集蛋白聚糖(Aggrecan)mRNA、Ⅱ型胶原蛋白(CollagenⅡ)mRNA的表达量,采用蛋白印迹法检测大鼠股骨远端软骨组织中Aggrecan、CollagenⅡ的蛋白表达量。结果:①大鼠饲养结果。KOA模型组大鼠因肺栓塞死亡2只,独活寄生汤治疗组大鼠因腹泻死亡1只,盐酸氨基葡萄糖治疗组大鼠因肺栓塞死亡1只。②大鼠胫骨近端软骨组织中KOA相关基因的RNA表达结果。正常对照组、KOA模型组、独活寄生汤治疗组、盐酸氨基葡萄糖治疗组大鼠胫骨近端软骨组织中miR-675-3p、lncRNA H19、Aggrecan mRNA、CollagenⅡmRNA的表达量比较,组间差异均有统计学意义(F=83.050,P=0.000; F=436.003,P=0.000; F=129.212,P=0.000; F=135.844,P=0.000)。KOA模型组、独活寄生汤治疗组、盐酸氨基葡萄糖治疗组大鼠胫骨近端软骨组织中miR-675-3p、Aggrecan mRNA、CollagenⅡmRNA的表达量均低于正常对照组(miR-675-3p:P=0.000; P=0.003; P=0.002; Aggrecan mRNA:P=0.000; P=0.000; P=0.000; CollagenⅡmRNA:P=0.000; P=0.000; P=0.000); KOA模型组大鼠胫骨近端软骨组织中lncRNA H19的表达量低于正常对照组(P=0.002),独活寄生汤治疗组、盐酸氨基葡萄糖治疗组大鼠胫骨近端软骨组织中lncRNA H19的表达量与正常对照组比较,差异无统计学意义(P=0.058,P=0.069); 独活寄生汤治疗组、盐酸氨基葡萄糖治疗组大鼠胫骨近端软骨组织中miR-675-3p、Aggrecan mRNA、CollagenⅡmRNA的表达量均高于KOA模型组(miR-675-3p:P=0.000; P=0.000; Aggrecan mRNA:P=0.000; P=0.000; CollagenⅡmRNA:P=0.000; P=0.000); 独活寄生汤治疗组大鼠胫骨近端软骨组织中miR-675-3p、lncRNA H19、Aggrecan mRNA、CollagenⅡmRNA的表达量与盐酸氨基葡萄糖治疗组比较,组间差异均无统计学意义(P=0.922; P=0.778; P=0.857; P=0.904)。③大鼠股骨远端软骨组织中软骨组成相关基因的蛋白表达结果。正常对照组、KOA模型组、独活寄生汤治疗组、盐酸氨基葡萄糖治疗组的大鼠股骨远端软骨组织中Aggrecan和CollagenⅡ的蛋白表达量比较,组间差异均有统计学意义(F=58.118,P=0.002; F=16.625,P=0.001)。KOA模型组、独活寄生汤治疗组大鼠股骨远端软骨组织中Aggrecan的蛋白表达量均低于正常对照组(P=0.003; P=0.004),盐酸氨基葡萄糖治疗组大鼠股骨远端软骨组织中Aggrecan的蛋白表达量与正常对照组相比,差异无统计学意义(P=0.078),KOA模型组、独活寄生汤治疗组、盐酸氨基葡萄糖治疗组大鼠股骨远端软骨组织中CollagenⅡ的蛋白表达量均低于正常对照组(P=0.000; P=0.028; P=0.018),独活寄生汤治疗组、盐酸氨基葡萄糖治疗组大鼠股骨远端软骨组织中Aggrecan和CollagenⅡ的蛋白表达量均高于KOA模型组(Aggrecan:P=0.025; P=0.034; CollagenⅡ:P=0.003; P=0.004),独活寄生汤治疗组大鼠股骨远端软骨组织中Aggrecan和CollagenⅡ的蛋白表达量与盐酸氨基葡萄糖治疗组比较,组间差异均无统计学意义(P=0.999; P=0.775)。结论:独活寄生汤治疗大鼠KOA的作用机制,可能与其能够上调miR-675-3p、lncRNA H19的表达进而促进Aggrecan、CollagenⅡ的表达有关。
Abstract:
Objective:To explore the mechanism of action(MoA)of Duhuo Jisheng Tang(独活寄生汤,DHJST)in treatment of knee osteoarthritis(KOA)in rats.Methods:Among the 66 rats,48 ones were selected by using random digits table and subjected to surgery for inducing KOA by using modified Hulth method.Three normal rats and 3 model rats were randomly selected for confirming whether the models were built successfully.After successful modeling,the remained 15 normal rats were assigned into the normal control group,and the 45 KOA model rats were randomly divided into KOA model group,DHJST treatment group and glucosamine hydrochloride(GAH)treatment group by using random digits table,15 cases in each group.The rats in normal control group,KOA model group,DHJST treatment group and GAH treatment group were intragastric administrated with 0.9% normal saline(NS),0.9% NS,DHJST with concentration of 0.93 g/mL and GAH with concentration of 0.015 g/mL in daily dosage of 10 mL/kg respectively for consecutive 12 weeks.After the end of intervention,the cartilage tissues were harvested from bilateral proximal tibiae and terminal femora of rats in each group.The expression levels of miR-675-3p,long non-coding RNA(lncRNA)H19,Aggrecan mRNA and CollagenⅡmRNA in cartilage tissues of proximal tibiae were detected by using real-time quantitative PCR(RT-qPCR),and the protein expression levels of Aggrecan and CollagenⅡin cartilage tissues of terminal femora were detected by using Western-blot assays.Results:①Two rats in KOA model group,1 case in DHJST treatment group and 1 case in GAH treatment group died for pulmonary embolism(PE),diarrhea and PE respectively.②The relults of analysis on RNA expression of KOA-related genes in cartilage tissues of rat proximal tibiae.There was statistical difference in the expression levels of miR-675-3p,lncRNA H19,Aggrecan mRNA and CollagenⅡmRNA in cartilage tissues of rat proximal tibiae among normal control group,KOA model group,DHJST treatment group and GAH treatment group(F=83.050,P=0.000; F=436.003,P=0.000; F=129.212,P=0.000; F=135.844,P=0.000).The miR-675-3p,Aggrecan mRNA and CollagenⅡmRNA were lowly expressed in cartilage tissues of rat proximal tibiae in KOA model group,DHJST treatment group and GAH treatment group compared to normal control group(miR-675-3p:P=0.000; P=0.003; P=0.002; P=0.000; Aggrecan mRNA:P=0.000; P=0.000; P=0.000; CollagenⅡmRNA:P=0.000; P=0.000; P=0.000)...

参考文献/References:

[1] 敖秀兰,张婷,程维,等.老年膝关节骨关节炎患者生活质量及影响因素[J].中国老年学杂志,2017,37(6):1522-1524.
[2] 唐布敏,郑晓燕,万巧琴,等.膝关节骨性关节炎患者生活质量及干预研究现状[J].现代预防医学,2016,43(1):121-123.
[3] 曹龙军,章礼勤,周石,等.膝关节骨性关节炎患者股四头肌动员能力和肌力储备改变的研究[J].中国康复医学杂志,2012,27(1):30-34.
[4] 吕苏梅,张瑞丽.中老年膝骨关节炎的流行病学研究进展[J].中国老年学杂志,2016,36(16):4133-4135.
[5] 郑春松,付长龙,叶蕻芝,等.独活寄生汤在骨伤科的临床应用与实验研究进展[J].风湿病与关节炎,2015,4(12):62-66.
[6] 吴广文,褚剑锋,许惠凤,等.独活寄生汤的药理作用及其在治疗骨性关节炎中的应用[J].中医正骨,2012,24(1):37-39.
[7] 许丽梅,李慧,许云腾,等.基于NF-κB信号通路探讨独活寄生汤抑制脂多糖诱导的软骨细胞炎症反应的作用机制[J].中医正骨,2019,31(7):9-14.
[8] 郑梓灌,林涛,吴丽芳.独活寄生汤口服联合二乌红花饮离子导入治疗膝骨关节炎肾虚髓亏证[J].中医正骨,2019,31(5):38-40.
[9] 赵忠胜,黄云梅,郑若曦,等.独活寄生汤对改良Hulth法造模大鼠膝骨关节炎软骨形态的影响[J].福建中医药,2019,50(5):59-62.
[10] SONG J,AHN C,CHUN C H,et al.A long non-coding RNA,GAS5,plays a critical role in the regulation of miR-21 during osteoarthritis[J].J Orthop Res,2014,32(12):1628-1635.
[11] 魏伟,吴希美,李元健.药理实验方法学[M].4版.北京:人民卫生出版社,2010:71-72.
[12] 周绪昌,张苗,邹军,等.长链非编码RNA H19对骨关节炎的影响[J].中华骨质疏松和骨矿盐疾病杂志,2020,13(2):184-190.
[13] BAI Y,DAI X,HARRISON A P,et al.RNA regulatory networks in animals and plants:a long noncoding RNA perspective[J].Brief Funct Genomics,2015,14(2):91-101.
[14] PEARSON M J,PHILP A M,HEWARD J A,et al.Long intergenic noncoding RNAs mediate the human chondrocyte inflammatory response and are differentially expressed in osteoarthritis cartilage[J].Arthritis Rheumatol,2016,68(4):845-856.
[15] TIAN F,WANG J H,ZHANG Z H,et al.LncRNA SNHG7/miR-34a-5p/SYVN1 axis plays a vital role in proliferation,apoptosis and autophagy in osteoarthritis[J].Biol Res,2020,53(1):9.
[16] 高宁阳,丁立,庞坚,等.miRNAs与骨关节炎关系的研究进展[J].中医正骨,2015,27(12):74-77.
[17] XIE F,LIU Y L,CHEN X Y,et al.Role of microRNA,lncRNA,and exosomes in the progression of osteoarthritis:a review of recent literature[J].Orthop Surg,2020,12(3):708-716.
[18] SONG J,KIM D,HAN J,et al.PBMC and exosome-derived Hotair is a critical regulator and potent marker for rheumatoid arthritis[J].Clin Exp Med,2015,15(1):121-126.
[19] FU M,HUANG G,ZHANG Z,et al.Expression profile of long noncoding RNAs in cartilage from knee osteoarthritis patients[J].Osteoarthritis Cartilage,2015,23(3):423-432.
[20] SEIDL C I,MURPHY C L.Dual and opposing regulation of MMP1 and MMP13 by both arms of miR-675 in human articular chondrocytes[J].Cell Physiol Biochem,2019,53(1):172-185.
[21] CAI X,CULLEN B R.The imprinted H19 noncoding RNA is a primary microRNA precursor[J].RNA,2007,13(3):313-316.
[22] SHEN X F,CHENG Y,DONG Q R,et al.MicroRNA-675-3p regulates IL-1beta-stimulated human chondrocyte apoptosis and cartilage degradation by targeting GNG5[J].Biochem Biophys Res Commun,2020,527(2):458-465.
[23] ZHU B,CUI G,ZHANG Q,et al.Desumoylation of aggrecan and collagen II facilitates degradation via aggrecanases in IL-1beta-mediated osteoarthritis[J].J Pain Res,2019,12:2145-2153.
[24] VARELA-EIRIN M,LOUREIRO J,FONSECA E,et al.Cartilage regeneration and ageing:targeting cellular plasticity in osteoarthritis[J].Ageing Res Rev,2018,42:56-71.
[25] 范凯健,吴菁,李钦,等.基质金属蛋白酶13在软骨重塑和关节炎中的研究进展[J].中国药理学通报,2018,34(5):607-611.
[26] DUDEK K A,LAFONT J E,MARTINEZ-SANCHEZ A,et al.Type Ⅱ collagen expression is regulated by tissue-specific miR-675 in human articular chondrocytes[J].J Biol Chem,2010,285(32):24381-24387.

相似文献/References:

[1]樊庆阳,任凯晶.定制3D打印切模辅助全膝关节置换术治疗 膝骨关节炎合并股骨干骨折畸形愈合[J].中医正骨,2015,27(11):37.
[2]刘晓雅,孙永强,刘国杰.主动快速康复锻炼对全膝关节置换术后关节活动度的影响[J].中医正骨,2015,27(09):73.
[3]郑春松,叶蕻芝,李西海,等.透骨消痛胶囊中补肾柔肝药和活血祛风药治疗 骨关节炎作用方式的计算机模拟比较[J].中医正骨,2015,27(07):6.
 ZHENG Chunsong,YE Hongzhi,LI Xihai,et al.Comparison of the mode of action of Bushen Rougan(补肾柔肝)drugs versus Huoxue Qufeng(活血祛风)drugs contained in Tougu Xiaotong Jiaonang(透骨消痛胶囊)for the treatment of osteoarthritis:A computer simulation study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):6.
[4]宋兵华,孙俊英,倪增良,等.全膝关节置换术前CT测量股骨后髁角的临床意义[J].中医正骨,2015,27(07):38.
[5]郑春松,叶蕻芝,李西海,等.独活寄生汤含药血清对白细胞介素1β诱导的 退变关节软骨细胞中基质金属蛋白酶 和环氧化酶2表达的影响[J].中医正骨,2015,27(12):1.
 ZHENG Chunsong,YE Hongzhi,LI Xihai,et al.Impact of Duhuo Jisheng Tang(独活寄生汤)medicated serum on expression of matrix metalloproteinase and cyclooxygenase 2 in degenerative articular chondrocytes induced by interleukin-1 beta[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):1.
[6]王金良,孙京涛,李玲,等.骨水泥联合螺钉修复全膝关节置换术中 胫骨平台内侧骨缺损[J].中医正骨,2015,27(12):55.
[7]冯荣,王平,李炳奇,等.铍针刺络拔罐结合中药口服治疗膝骨关节炎合并 原发性血小板增多症1例[J].中医正骨,2015,27(12):73.
[8]蔡云仙.围手术期耳穴按压联合平衡针疗法 在全膝关节置换术后镇痛中的应用[J].中医正骨,2015,27(06):41.
[9]张荣,王健.人工全膝关节置换术的围手术期心理护理[J].中医正骨,2015,27(05):77.
[10]喻长纯,杨明路,王战朝.不同手术方式治疗胫骨平台骨折畸形愈合的体会[J].中医正骨,2015,27(03):37.
[11]孟维娜,明立功,王新德,等.关节镜下清理联合腓骨近1/3段截骨治疗膝骨关节炎[J].中医正骨,2015,27(11):40.
[12]明立功,孟维娜,王新德,等.腓骨近端截骨治疗内侧间室膝骨关节炎的近期疗效观察[J].中医正骨,2015,27(10):25.
[13]张杰,王人彦,张玉柱.膝骨关节炎的治疗进展[J].中医正骨,2015,27(10):68.
[14]梁朝,蔡静怡,闫立,等.针刀疗法改善膝骨关节炎早期疼痛症状的疗效评价[J].中医正骨,2015,27(09):9.
 LIANG Zhao,CAI Jingyi,YAN Li,et al.Evaluation of the curative effect of needle-knife therapy for relieving knee pain in patients with early knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):9.
[15]王建武,党建军,李强,等.四联疗法治疗膝骨关节炎[J].中医正骨,2015,27(08):44.
[16]刘红娟,郭会利,郭树农.云克联合中药治疗膝骨关节炎的护理[J].中医正骨,2015,27(08):75.
[17]陈卫衡.探索建立系统的膝骨关节炎中医临床科研范式 和理论体系[J].中医正骨,2015,27(07):1.
[18]帅波,沈霖,杨艳萍,等.加味青娥丸治疗膝骨关节炎的作用机制研究[J].中医正骨,2015,27(07):15.
 SHUAI Bo,SHEN Lin,YANG Yanping,et al.Study on the mechanism of action of Jiawei Qing'e Wan(加味青娥丸)for the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):15.
[19]梅其杰,袁长深,段戡,等.壮药骨痹方烫熨联合运动疗法治疗膝骨关节炎的临床研究[J].中医正骨,2015,27(07):27.
 MEI Qijie,YUAN Changshen,DUAN Kan,et al.Clinical study of the curative effect of hot compressing and rubbing with packet of Gubi Fang(骨痹方)combined with exercise therapy in the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):27.
[20]王丹辉,张燕,刘丽娟,等.重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白 关节腔注射联合中药薰洗治疗膝骨关节炎的临床研究[J].中医正骨,2015,27(07):31.
 WANG Danhui,ZHANG Yan,LIU Lijuan,et al.Clinical study on intra-articular injection of TypeⅡrecombinant human tumor necrosis factor receptor-Fc fusion protein combined with Chinese herbal steaming and washing therapy for treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):31.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金项目(81774345)
通讯作者:吴广文 E-mail:wuguangwenfj@163.com
更新日期/Last Update: 1900-01-01